Lifecode

Lifecode, Inc. is a molecular diagnostics company specializing in next-generation sequencing (NGS) technology. It develops a range of NGS-based cancer assays, notably the Lifecode Pan Cancer Somatic Panel, which is designed to aid in the diagnosis and treatment of various types of cancer, including metastatic, rare, and refractory cancers. The company focuses on making molecular tumor profiling more accessible and interpretable for patients, healthcare providers, and payers by presenting complex genomic and therapeutic data in a meaningful manner. Lifecode collaborates with experts in data science, software engineering, and molecular biology to enhance its offerings. Founded in 2011 and based in Foster City, California, Lifecode operates as a subsidiary of MedGenome Labs Private Ltd. Its clinical services are currently available to a select group of physicians in the United States, reflecting its commitment to advancing personalized cancer care through innovative diagnostic solutions.